Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 334

Similar articles for PubMed (Select 15653173)

1.

A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.

Licastro F, Chiappelli M, Grimaldi LM, Morgan K, Kalsheker N, Calabrese E, Ritchie A, Porcellini E, Salani G, Franceschi M, Canal N.

Neurobiol Aging. 2005 Apr;26(4):449-53.

PMID:
15653173
2.

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

Licastro F, Pedrini S, Govoni M, Pession A, Ferri C, Annoni G, Casadei V, Veglia F, Bertolini S, Grimaldi LM.

Neurosci Lett. 1999 Aug 6;270(3):129-32.

PMID:
10462111
3.

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST.

Nat Genet. 1995 Aug;10(4):486-8. Erratum in: Nat Genet 1995 Sep;11(1):104.

PMID:
7670501
4.

APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.

Barabash A, Marcos A, Ancín I, Vázquez-Alvarez B, de Ugarte C, Gil P, Fernández C, Encinas M, López-Ibor JJ, Cabranes JA.

Neurobiol Aging. 2009 Aug;30(8):1254-64. Epub 2007 Dec 19.

PMID:
18078695
5.

Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.

DeKosky ST, Aston CE, Kamboh MI.

Ann N Y Acad Sci. 1996 Dec 16;802:27-34.

PMID:
8993481
6.

[ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].

Hernández-Charro B, Moreno S, Valiente A, Manubens JM, Villar MD, Ramos-Arroyo MA.

Med Clin (Barc). 2004 Sep 4;123(7):251-4. Spanish.

PMID:
15482730
7.

alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.

Licastro F, Chiappelli M, Thal LJ, Masliah E.

Arch Gerontol Geriatr Suppl. 2004;(9):243-51.

PMID:
15207421
8.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
9.

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T.

Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74.

PMID:
9850873
10.

Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.

Porcellini E, Davis EJ, Chiappelli M, Ianni E, Di Stefano G, Forti P, Ravaglia G, Licastro F.

Curr Pharm Des. 2008;14(26):2659-64.

PMID:
18991685
11.

No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.

Fallin D, Reading S, Schinka J, Hoyne J, Scibelli P, Gold M, Crawford F, Mullan M.

Am J Med Genet. 1997 Apr 18;74(2):192-4.

PMID:
9129722
12.

No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.

Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, Han SH, Woo JI.

Am J Med Genet. 2000 Apr 24;91(5):355-8.

PMID:
10766998
13.

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.

Murphy GM Jr, Sullivan EV, Gallagher-Thompson D, Thompson LW, van Duijn CM, Forno LS, Ellis WG, Jagust WJ, Yesavage J, Tinklenberg JR.

Neurology. 1997 May;48(5):1313-6.

PMID:
9153464
14.

No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.

Helisalmi S, Mannermaa A, Lehtovirta M, Ryynänen M, Riekkinen P Sr, Soininen H.

Neurosci Lett. 1997 Aug 1;231(1):56-8.

PMID:
9280167
15.

Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

Rodríguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O.

J Neurol. 2006 Feb;253(2):181-5. Epub 2005 Aug 17.

PMID:
16096813
16.

Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease.

Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, Xuereb J, Wischik C, Harrington C, Kalsheker NA.

Hum Genet. 1997 Jan;99(1):27-31.

PMID:
9003488
17.

Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease.

Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S.

J Neural Transm. 1996;103(10):1205-10.

PMID:
9013407
18.

Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.

Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H, Shoji S.

J Neurol Sci. 1997 Nov 25;152(2):136-9.

PMID:
9415533
19.

Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.

Scacchi R, Ruggeri M, Gambina G, Martini MC, Ferrari G, Corbo RM.

Neurobiol Aging. 2001 May-Jun;22(3):413-6.

PMID:
11378247
20.

Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.

Panza F, Solfrizzi V, Torres F, Mastroianni F, Colacicco AM, Basile AM, Capurso C, D'Introno A, Del Parigi A, Capurso A.

Neurosci Lett. 2000 Oct 6;292(2):79-82.

PMID:
10998553
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk